Collaborations & Alliances

Shire, Rani Collaborate on Oral Delivery of Factor VIII Therapy

To evaluate Rani's Pill technology for the oral delivery of FVIII therapy for hemophilia A

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Shire plc and Rani Therapeutics have entered a collaboration to exclusively conduct research using the Rani Pill technology for the oral delivery of factor VIII (FVIII) therapy for hemophilia A. Shire has an exclusive option to negotiate a license to develop and commercialize the technology for delivery of FVIII therapy following feasibility studies. Shire has also made an equity investment in Rani Therapeutics. Rani Therapeutics has developed a new approach for the oral delivery of large mol...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters